NIH-funded research R01 grant

Investigating how polyamines and hypusine affect beta-cell function in diabetes

Official title: The Role of Polyamines and Hypusine in Beta-Cell Dysfunction

Funded at University of Chicago · NIH-11003775 · Data updated 2026-11-12

This study is looking at how certain natural compounds affect the health of insulin-producing cells in the body, which could help us find new ways to protect these cells and prevent type 1 diabetes in people who are at risk.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$547,710
NIH project number5R01DK135832-02
Project IDNIH-11003775 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are at risk for or have been diagnosed with type 1 diabetes.

Less likely to help

Patients with type 2 diabetes or those without any form of diabetes may not benefit from this research.

What this research studies

This research focuses on understanding the role of polyamines and hypusine in the dysfunction of beta-cells, which are crucial for insulin production. By examining how these compounds influence the response of beta-cells to stress and inflammation, the research aims to uncover mechanisms that lead to type 1 diabetes. The study will utilize both mouse and human models to explore how manipulating the polyamine/hypusine pathway can protect beta-cells from damage. If successful, this could lead to new therapeutic strategies to preserve beta-cell function in individuals at risk for diabetes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that protect beta-cells and prevent or delay the onset of type 1 diabetes.

How similar studies have gone: Previous research has shown promising results in targeting the polyamine/hypusine pathway for protecting beta-cells, indicating potential for success in this approach.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Tersey, Sarah a. — University of Chicago
  • Study coordinator: Tersey, Sarah a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.